Maintenance of behavior changes in cardiorespiratory risk reduction: a clinical perspective from the Ornish Program

J H Billings1

  • 1Preventive Medicine Research Institute, Sausalito, California 94965, USA. jharpb@aol.com

Insights

This article discusses maintaining lifestyle changes for heart health, drawing on 15 years of experience with the Ornish Program. It highlights the program's success in reducing cardiac risk factors and improving adherence to lifestyle modifications.

Area of Science:

  • Cardiology
  • Behavioral Medicine
  • Public Health

Background:

  • Conference on Maintenance of Behavior Change in Cardiorespiratory Risk Reduction.
  • Author's clinical perspective from 15 years of experience.
  • Interest in the Ornish Program's success.

Purpose of the Study:

  • Provide an "outside-the-box" clinical reaction to conference reports.
  • Discuss the Ornish Program's effectiveness in lifestyle change.
  • Highlight factors contributing to long-term adherence.

Main Methods:

  • Edited remarks from a conference presentation.
  • Clinical experience with the Ornish Heart Disease Reversal Program.
  • Review of existing literature on the Ornish Program's outcomes.

Main Results:

  • The Ornish Program demonstrates success in reducing cardiac risk factors.
  • The program aids in altering the progression of coronary artery disease.
  • Sustained adherence to lifestyle changes is achievable.

Conclusions:

  • Lifestyle modification programs like Ornish's are effective for cardiorespiratory risk reduction.
  • Long-term adherence is a critical component of successful behavior change.
  • Clinical experience offers valuable insights into public health initiatives.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...